INDOUS logo

Indo Us Biotech Limited

INDOUS·NSE·
₹71.99▲ +0.35 (+0.49%)
Market Cap146.52 Cr
PE Ratio11.01
Volume4,521
Day High - Low74.97 - 71.50
52W High-Low159.00 - 70.00

Indo Us Biotech Limited (INDOUS): company summary

The company's revenue grew 6.2% annually, but net profit fell 18.0% year-on-year.

Indo Us Biotech Limited (INDOUS) is a micro-cap Fast Moving Consumer Goods company valued at ₹147 crore operating in Other Agricultural Products on the NSE and BSE.

Recent price move
Indo Us Biotech Limited last traded at ₹71.99, modestly up 0.49% on the day.
Recent developments
On 2026-09-16, the company released a preview for its Q2 FY27 results, highlighting concerns about margins.
Financial performance
The company's revenue grew 6.2% annually, but net profit fell 18.0% year-on-year. In the latest quarter, revenue rose 7.2% compared to the same quarter a year earlier, but net profit dropped 35.3%, indicating margin pressure.
Valuation multiples
The stock trades at 11.0 times earnings, a discount to the Fast Moving Consumer Goods median of 19.6, 1.68 times book value. It yields 0.3%.
Things to watch
Net profit margin narrowed 3.5 percentage points to 11.9%, and the latest quarter's net profit fell 35.3% compared to the same quarter a year earlier. The stock is 51.7% below its 52-week high.
Where it stands
Indous has seen strong revenue growth over the past five years, but profit growth has slowed, with net profit falling 18.0% annually. The latest quarter's net profit dropped 35.3% compared to the same quarter a year earlier, raising concerns about margin pressure.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
5.7/10
Fair
Fair Value
Sign in to see
ROE
14.18%
Average
P/E
11.01x
Cheap
Debt / Equity
0.40
Moderate
Industry
Fast Moving Consumer Goods
Other Agricultural Products
Overall View
Mixed

Price performance

Day₹71.50
₹74.97
52W₹70.00
₹159.00
DocStoX take

Supported by growth (9.0) and valuation (7.6), but held back by momentum (0.0). Growth looks strong at 9.0, but that is offset by momentum at 0.0. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
5.7
/10
Fair
Quality
Modest
ROE 14.2%
Valuation
Cheap
P/E 11.0×
Growth
Strong
Revenue +23.1% 5Y CAGR
Risk
Moderate
D/E 0.40
Momentum
Weak
2% of 52-week range

At a glance

Market Cap
₹147 Cr
52W High / Low
₹159 / ₹70
Dividend Yield
0.31%
Promoter Holding
68.29%
EPS (TTM)
₹6.54
Book Value
₹46.15

Key highlights

  • Profitable in all of the last 5 years
  • Undemanding at 11× earnings
  • Revenue compounding 23% a year
  • Momentum is weak (0.0/10)
  • Near the bottom of its 52-week range (2%)
4 Positives3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Fast Moving Consumer Goods stocks · Other Agricultural Products

Indo Us Biotech Limited peers in Fast Moving Consumer Goods

Other Fast Moving Consumer Goods stocks on the NSE & BSE. See the full Fast Moving Consumer Goods sector list.